Basic and clinical studies of S-1108 in the field of obstetrics and gynecology
Basic and clinical studies were performed, and the following results were obtained. S-1108, a new oral cephem antibiotic, was evaluated for its tissue concentration in female genital organs after administration of 100 and 200 mg doses (n=10). The peak serum levels in uterine artery and cubital vein...
Saved in:
Published in | CHEMOTHERAPY Vol. 41; no. Supplement1; pp. 589 - 593 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | Japanese |
Published |
Japanese Society of Chemotherapy
30.06.1993
|
Online Access | Get full text |
Cover
Loading…
Abstract | Basic and clinical studies were performed, and the following results were obtained. S-1108, a new oral cephem antibiotic, was evaluated for its tissue concentration in female genital organs after administration of 100 and 200 mg doses (n=10). The peak serum levels in uterine artery and cubital vein blood were 0.34μg/ml at 3 hours after the 100 mg dose, while genital tissue levels were 0.06-0.18μg/g. After administration of 200mg, serum levels and genital tissue levels were 0.24-0.44μg/ml and 0.12-0.17μg/g respectively at 4 hours. In clinical studies, S-1108 was administered to 9 patients (endometritis: 2, bartholinitis: 1, abscess of bartholin: 1, mastitis: 4, abscess of genitals: 1). The daily dose was 100mg three times a day. The total clinical efficacy rate was 8/9, and the bacteriological effect showed all organisms isolated (5 strains) eradicated after treatment. No serious adverse effects were observed in any of the cases. |
---|---|
AbstractList | Basic and clinical studies were performed, and the following results were obtained. S-1108, a new oral cephem antibiotic, was evaluated for its tissue concentration in female genital organs after administration of 100 and 200 mg doses (n=10). The peak serum levels in uterine artery and cubital vein blood were 0.34μg/ml at 3 hours after the 100 mg dose, while genital tissue levels were 0.06-0.18μg/g. After administration of 200mg, serum levels and genital tissue levels were 0.24-0.44μg/ml and 0.12-0.17μg/g respectively at 4 hours. In clinical studies, S-1108 was administered to 9 patients (endometritis: 2, bartholinitis: 1, abscess of bartholin: 1, mastitis: 4, abscess of genitals: 1). The daily dose was 100mg three times a day. The total clinical efficacy rate was 8/9, and the bacteriological effect showed all organisms isolated (5 strains) eradicated after treatment. No serious adverse effects were observed in any of the cases. |
Author | Matsuda, Seiji Oh, Kinki Hirayama, Hiroaki |
Author_xml | – sequence: 1 fullname: Matsuda, Seiji organization: Department of Obstetrics and Gynecology, Koto Hospital – sequence: 2 fullname: Oh, Kinki organization: Department of Obstetrics and Gynecology, Koto Hospital – sequence: 3 fullname: Hirayama, Hiroaki organization: Department of Obstetrics and Gynecology, Koto Hospital |
BookMark | eNpdkMlOwzAURS1UJErpP_gDSPCY2EuomKQKFu3eOM5L6yp1othd5O8Jw6Lq6t033Pukc4tmoQuA0D0lOaVMkge3h2OX9jDYfqRa8lzQfHPq-xaOEBI1UukrNKdKiWySYobmhBCdcVrIG7SM0VeEUEoKptgcfTzZ6B22ocau9cE72-KYTrWHiLsGb7LpUmEf8PQQNx7a-mfcVTFBGryLv87dGMB1bbcb79B1Y9sIy_-6QNuX5-3qLVt_vr6vHtfZgYoiZKK2hWyq0sma6YLrgnDLS8UJsVqBkqXUGkAUotIlLy1jTjnZaCY4qaYNX6Cvv9hDTHYHph_80Q6jsUPyrgVzicgIas4RXbQTpjOrHQwE_g2l63Fl |
ContentType | Journal Article |
Copyright | Japanese Society of Chemotherapy |
Copyright_xml | – notice: Japanese Society of Chemotherapy |
DOI | 10.11250/chemotherapy1953.41.Supplement1_589 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1884-5894 |
EndPage | 593 |
ExternalDocumentID | article_chemotherapy1953_41_Supplement1_41_Supplement1_589_article_char_en |
GroupedDBID | 53G AAUGY ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL DIK JSF JSH KQ8 RJT RZJ ZOHVM |
ID | FETCH-LOGICAL-j146n-4da65fb7c5d29639603a378300a98e857599ee464b9737a22c8c5f92430b99e3 |
ISSN | 0009-3165 |
IngestDate | Thu Aug 17 20:28:28 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Issue | Supplement1 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j146n-4da65fb7c5d29639603a378300a98e857599ee464b9737a22c8c5f92430b99e3 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/chemotherapy1953/41/Supplement1/41_Supplement1_589/_article/-char/en |
PageCount | 5 |
ParticipantIDs | jstage_primary_article_chemotherapy1953_41_Supplement1_41_Supplement1_589_article_char_en |
PublicationCentury | 1900 |
PublicationDate | 1993/06/30 |
PublicationDateYYYYMMDD | 1993-06-30 |
PublicationDate_xml | – month: 06 year: 1993 text: 1993/06/30 day: 30 |
PublicationDecade | 1990 |
PublicationTitle | CHEMOTHERAPY |
PublicationTitleAlternate | Chemother. |
PublicationYear | 1993 |
Publisher | Japanese Society of Chemotherapy |
Publisher_xml | – name: Japanese Society of Chemotherapy |
References | 9) 松田静治, 鈴木正明, 王欣暉, 二宮敬宇: NY-198の産婦人科領域における基礎的・臨床的検討. Chemotherapy 36 (S-2): 1085-1090, 1988 1) 久保田忠俊, 石倉公二, 南恭二, 元川清治, 中清水弘. 田中守, 三市能之, 羽島誠: 新経口セフェムS-1108および関連化合物の合成と構造活性相関. 日本薬学会第111年会, 東京, 1991 7) 松田静治, 他 (8施設): 産婦人科領域におけるCS-807の臨床応用. Chemotherapy 36 (S-1): 907-917, 1988 3) Yoshida T, Hamashima T, Komatsu Y, Nomura K, Kuwahara S: 5-1108, a New Oral Cephem: Antibacterial activity. 29th ICAAC, Abstr. No.368, Houston, Sep, 17-20, 1989 4) Yokota T, Arai K: S-1108: Antibacterial activity, stability to β-lactamase, affinity to bacterial penicillin-binding proteins, and synergy of bactericidal effect with serum complement or mousecultured macrophage of its active form, S-1006. 30 th ICAAC, Abstr. No.656, Atlanta, Oct. 21-24, 1990 8) 松田静治, 鈴木正明, 王欣暉: 産婦人科領域におけるCefdinirの臨床応用. Chemotherapy 37 (S-2): 915-921, 1989 10) 松田静治, 鈴木正明, 宮崎亮一郎, 王欣曜: 塵婦人科領域におけるT-3262の臨床応用. Chemotherapy 36 (S-9): 1209-1213, 1988 5) 由良二郎, 齋藤篤: 第40回日本化学療法学会総会, 新薬シンポジウム. S-1108, 名古屋, 1992 2) Nakashima M, Matsuno S, Yoshida T, Kimura Y, Oguma, Ishi H: Pharmacokinetics and safety of S-1108 in healthy volunteers, 29th ICAAC, Abstr. No.370, Houston, Sep. 17-20, 1989 6) 松田静治, 柏倉高, 鈴木正明: T-2588の産婦人科領域における臨床応用. Chemotherapy 34 (S-2): 850-853, 1986 |
References_xml | |
SSID | ssib001106282 ssj0000626693 ssib031782880 ssib005879733 ssib008506721 |
Score | 1.2859741 |
Snippet | Basic and clinical studies were performed, and the following results were obtained. S-1108, a new oral cephem antibiotic, was evaluated for its tissue... |
SourceID | jstage |
SourceType | Publisher |
StartPage | 589 |
Title | Basic and clinical studies of S-1108 in the field of obstetrics and gynecology |
URI | https://www.jstage.jst.go.jp/article/chemotherapy1953/41/Supplement1/41_Supplement1_589/_article/-char/en |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | CHEMOTHERAPY, 1993/06/30, Vol.41(Supplement1), pp.589-593 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6FIiEuFQgQ0FLtgSMOfuza3mNBqSKqlFeQyslar9cokeqgNDmkf40_x7cPP1o4FAQXy1lnx1nPl9nZ9cx8hLysE80zwbHI0TILWBkZNsCUByzKckBIZKUw-c6zs3T6hb075-ej0Y9B1NJ2U47V1W_zSv5Gq2iDXk2W7B9othOKBpxDvzhCwzjeSsdv5KUvt9onOLq4QJuLEpjg-zaQ0YaqmeZVCcWauvyuOvO3XaNVv7feFi2YTmbv59PJp-MPna87k5vLbWWdzc96sVx0-7N2Z-bUkDD0G9lruZMX9rs4X0l_qfL5dkkbC9eafkzZhgqzCyK1QSL6wqeH7a7ZVgGL7pgfxtqZ0zxnAc8djXFrb12hK48ry11qN0KjgRnljlbIz8jccSj-auzhvkFFavBzzEvBMYvGA7FFJ-xaWW2vtOJm74JFxbD3jY8QVvRd5RowvEPuxoC7iSc9_Th4BRmZ9NRBLbQ8E9nAtzalAge16eDHYfHrjalzI-A7iY4J0DzZe-RVO-7Xtxg1nKollhhteKL1mOYPyL5f6tBjN46HZLSUj8iZxSwF8miLWeoxS1c1dZili4biptRi1jT3mLU9e8w-JvOTyfztNPCcHsESc3ITsEqmvC4zxasYth_r50QmMAthKEWuLV2s0JqlrMTDymQcq1zxWsQsCUtcSZ6QvWbV6KeEilBmXDORMKWYUFpoSJER-qahqmrxjHx1oy--u7otxb9T-fP_KPuA3O__h4dkb7Pe6hdwfDflkQXYT8Cis5o |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Basic+and+clinical+studies+of+S-1108+in+the+field+of+obstetrics+and+gynecology&rft.jtitle=CHEMOTHERAPY&rft.au=Matsuda%2C+Seiji&rft.au=Oh%2C+Kinki&rft.au=Hirayama%2C+Hiroaki&rft.date=1993-06-30&rft.pub=Japanese+Society+of+Chemotherapy&rft.issn=0009-3165&rft.eissn=1884-5894&rft.volume=41&rft.issue=Supplement1&rft.spage=589&rft.epage=593&rft_id=info:doi/10.11250%2Fchemotherapy1953.41.Supplement1_589&rft.externalDocID=article_chemotherapy1953_41_Supplement1_41_Supplement1_589_article_char_en |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-3165&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-3165&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-3165&client=summon |